↓ Skip to main content

Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controll…

Overview of attention for article published in Neuropsychopharmacology, April 2024
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
28 X users
reddit
1 Redditor
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study
Published in
Neuropsychopharmacology, April 2024
DOI 10.1038/s41386-024-01862-x
Pubmed ID
Authors

Mark E. Schmidt, Iva Kezic, Vanina Popova, Rama Melkote, Peter Van Der Ark, Darrel J. Pemberton, Guy Mareels, Carla M. Canuso, Maurizio Fava, Wayne C. Drevets

X Demographics

X Demographics

The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 May 2024.
All research outputs
#2,532,430
of 25,870,142 outputs
Outputs from Neuropsychopharmacology
#1,237
of 5,224 outputs
Outputs of similar age
#19,951
of 204,255 outputs
Outputs of similar age from Neuropsychopharmacology
#6
of 34 outputs
Altmetric has tracked 25,870,142 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,224 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.3. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,255 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.